β-globin restored autologous hematopoietic stem cells Clinical Trials
3 recruitingBiologic
Early Phase 12Phase 11
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
Thalassemia
Shenzhen Hemogen10 enrolled1 locationNCT05745532
Recruiting
Early Phase 1
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
Thalassemia
Shenzhen Hemogen3 enrolled1 locationNCT05864170
Recruiting
Phase 1
Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.
Thalassemia
Shenzhen Hemogen8 enrolled3 locationsNCT06655662